Retina

The number of patients with retinal vascular diseases is expected to increase over time due to the aging population and lifestyle changes

Our top 10 print stories highlight the core content concepts we explored this year

Espansione Group's Light Modulation Low-level Light Therapy (LLLT) is used in ophthalmology and dermatology

The European Commission will assess the marketing authorisation for Eydenzelt (reference product Eylea)

The PFS is approved for treatment of neovascular age-related macular degeneration, diabetic macular oedema and macular oedema following retinal vein occlusion

A retrospective study assessed elevated neutrophil-to-lymphocyte ratios and systemic immune-inflammation index levels in patients with different subtypes of DMO

Clinicians must consider redefining the metrics and intention behind functional outcomes, according to experts from the European Association for the Study of Diabetic Eye Complications

Presentation closely resembled mitogen-activated extracellular signal-regulated kinase inhibitor–associated retinopathy

The annual meeting brought fourth announcements and insights from companies in the retina care space

Dr Wykoff addressed the top three questions retina specialists have about retinal non-perfusion

EAB members from Ophthalmology Times Europe, Ophthalmology Times and Modern Retina are presenting in Florence

Breakthrough technologies are raising the ceiling for functional visual outcomes

What to expect from 4 days in the Fortezza de Basso

OCU410ST is indicated for the treatment of ABCA4-associated retinopathies including Stargardt disease, retinitis pigmentosa and cone-rod dystrophy 3 (CORD3)

ARVN001 is indicated for the treatment of uveitic macular oedema and certain other ophthalmic indications

OPUVIZ, previously known as the biosimilar candidate SB15, has been approved for the treatment of nAMD, DME and other retinal diseases

The positive opinion marks a key regulatory step towards the approval of FYB203, which will go by the trade names AHZANTIVE and Baiama in the European Union

The CRL comes in response to a supplemental New Drug Application for Izervay, a treatment for geographic atrophy secondary to age-related macular degeneration

Optical coherence tomography will be in all eye care services by October 2025

Arun Upadhyay, PhD, discusses new study findings from trials of OCU400 (Ocugen)

HG202, by HuidaGene Therapeutics, is formulated for clinical use in treating neovascular age-related macular degeneration

New analysis brings disease progression and therapeutics into focus

This year’s Barcelona meeting brought together award-winning research data and leaders in the retina field

Caffeine has been shown to temporarily increase intraocular pressure and reduce blood flow in critical ocular regions

New investment from Sanoptis will support Ikerian technology for large-scale, AI-enabled data management